PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies. Yang Z, Tian H, Li L, Li C, et al. Int J Cancer 2022;151:717-729.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang Z, Tian H, Li L, Li C, et al. PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies. Int J Cancer 2022;151:717-729.
PMID: 35612583